PYRIDIUM TABLET

Страна: Канада

Язык: английский

Источник: Health Canada

Активный ингредиент:

PHENAZOPYRIDINE HYDROCHLORIDE

Доступна с:

SEARCHLIGHT PHARMA INC

код АТС:

G04BX06

ИНН (Международная Имя):

PHENAZOPYRIDINE

дозировка:

100MG

Фармацевтическая форма:

TABLET

состав:

PHENAZOPYRIDINE HYDROCHLORIDE 100MG

Администрация маршрут:

ORAL

Штук в упаковке:

250ML

Тип рецепта:

Prescription

Терапевтические области:

ANTIPRURITICS AND LOCAL ANESTHETICS

Обзор продуктов:

Active ingredient group (AIG) number: 0106949001; AHFS:

Статус Авторизация:

APPROVED

Дата Авторизация:

2005-07-08

Характеристики продукта

PRESCRIBING INFORMATION
Pr
PYRIDIUM
Phenazopyridine Hydrochloride Tablets USP
100 mg and 200 mg
Urinary Tract Analgesic
Date of Preparation:
OCT 24, 2022
Searchlight Pharma Inc.
1600 Notre-Dame West, Suite 312
Montreal, Quebec
H3J 1M1
Submission Control No.: 267654


PYRIDIUM
®
(Phenazopyridine Hydrochloride) – Prescribing information Page 2 of
16
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.................................... 3
SUMMARY PRODUCT INFORMATION
.................................................... 3
INDICATIONS AND CLINICAL USE
.......................................................... 3
CONTRAINDICATIONS
...............................................................................
4
WARNINGS AND PRECAUTIONS
.............................................................. 4
ADVERSE REACTIONS
................................................................................
6
DRUG INTERACTIONS
................................................................................
7
DOSAGE AND ADMINISTRATION
............................................................ 7
OVERDOSAGE...............................................................................................
8
ACTION AND CLINICAL PHARMACOLOGY
.......................................... 8
STORAGE AND STABILITY
........................................................................
9
DOSAGE FORMS, COMPOSITION AND PACKAGING ........................... 9
PART II: SCIENTIFIC INFORMATION
.......................................................... 10
PHARMACEUTICAL
INFORMATION...................................................... 10
DETAILED PHARMACOLOGY
................................................................. 10
TOXICOLOGY
.............................................................................................
10
REFERENCES...............................................................................................
12
PART III: CONSUMER INFORMATION
......................................................... 13

